Filing Details

Accession Number:
0001209191-19-015622
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-04 16:25:47
Reporting Period:
2019-02-28
Accepted Time:
2019-03-04 16:25:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1427925 Acelrx Pharmaceuticals Inc ACRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1700225 J. Vincent Angotti C/O Acelrx Pharmaceuticals, Inc.
351 Galveston Drive
Redwood City CA 94063
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-28 3,234 $2.81 257,884 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Balance includes non-reportable acquisition of 3,234 shares of Common Stock through the Company's Employee Stock Purchase Plan.